Lilly Launches TuneLab AI & ML Platform for Biotech Research

Today Eli Lilly and Company announced Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that enables biotech firms to access sophisticated models for drug discovery based on decades of Lilly data...

Sun Pharmas Halol Plant Receives OAI Status from USFDA Inspection

Sun Pharmaceutical Industries declared that the US Food and Drug Administration (USFDA) has moved its Halol manufacturing plant in Gujarat to Official Action Indicated (OAI). The decision follows by the detailed examination.

Pfizer & BioNTech Show Strong Results for LP.8.1 Vaccine

Pfizer Inc. and BioNTech SE announced promising topline findings from a phase 3 study of their LP.8.1-adapted Comirnaty Covid-19 vaccine (2025-2026 Formula) that targets the SARS-CoV-2 evolution. The study involved adults aged 65 and older and...

MedTech Expo 2025 Concludes, India Eyes Self-Reliance

Amit Agrawal, Secretary, Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India (GoI), highlighted the quantum jump by Indian Medical Devices sector and reiterated commitment to support the industry...

Alembic Pharma Gets USFDA Nod for Phytonadione Injection

Alembic Pharmaceuticals (Alembic) announced the receipt of final approval by the US Food & Drug Administration

Drug-Resistant Hypertension in India May Ease With New Drug

Baxdrostat is a new blood pressure medication created by AstraZeneca that has been seen to lower the risk of cardiovascular in patients with resistant hypertension

Lilly's Jaypirca Delays Blood Cancer Progression in Study

Eli Lilly's (LLY.N), opens new tab approved blood cancer therapy Jaypirca has demonstrated its ability to delay disease progression in patients who had not received prior treatment, as evidenced by a late-stage study, positioning it as a potential

Alcon Launches UNITY VCS and CS Eye Surgery Systems in India

Alcon, a prominent leader in eye care committed to enhancing vision, has recently unveiled the UNITY Vitreoretinal Cataract System (VCS) and the UNITY Cataract System (CS) in India.

SPL Infusion Begins Production at New Pune IV Fluid Plant

Sanjivani Paranteral Limited's subsidiary, SPL Infusion Pvt. Ltd., has initiated commercial production at its newly established IV Fluid Infusion Plant located in Pune, Maharashtra, effective from 6th September 2025, following the acquisition of the

Akums Expands Access to Eurasian Pharma Markets

Akums Drugs & Pharmaceuticals Ltd. has said that its Hormonal Manufacturing Plant has received a Good Manufacturing Practice (GMP) Certificate from the (BEAEU)

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.